Table 1.
Summary statistics of mean (%), standard deviation (SD, %) and heritability estimates (h2), additive genetic variance and coefficient of variation (CV, %)
| Trait a | Name | Mean ± SD | Additive genetic variance | Residual variance | CV, % | h2 ± SE |
|---|---|---|---|---|---|---|
| Saturated FA | ||||||
| C14:0 | Myristic | 2.97 ± 0.6 | 1.24E-01 | 2.42E-01 | 20.31 | 0.34 ± 0.16 |
| C16:0 | Palmitic | 27.46 ± 4.06 | 8.35E-02 | 1.64E+ 01 | 14.78 | 0.01 ± 0.07 |
| C18:0 | Stearic | 11.96 ± 2.65 | 1.32E+ 00 | 4.88E+ 00 | 22.12 | 0.21 ± 0.13 |
| C20:0 | Arachidic | 0.08 ± 0.02 | 8.60E-06 | 4.01E-04 | 24.74 | 0.02 ± 0.07 |
| C22:0 | Behenic | 0.02 ± 0.01 | 9.10E-06 | 2.63E-05 | 36.16 | 0.26 ± 0.16 |
| C24:0 | Methyl tetracosanoate | 0.04 ± 0.02 | 3.37E-05 | 4.44E-04 | 58.88 | 0.07 ± 0.12 |
| Monounsaturated FA | ||||||
| C14:1 cis-9 | Methyl myristoleate | 0.93 ± 0.3 | 3.77E-02 | 5.02E-02 | 32.23 | 0.43 ± 0.17 |
| C16:1 cis-9 | Methyl palmitoleate | 4.22 ± 0.94 | 5.97E-02 | 7.63E-01 | 22.17 | 0.07 ± 0.12 |
| C18:1 cis-9 | Oleic | 46.87 ± 4.48 | 5.12E+ 00 | 1.53E+ 01 | 9.55 | 0.25 ± 0.17 |
| C20:1 cis-11 | cis-11-eicosenoic acid methyl ester | 0.48 ± 0.14 | 3.10E-03 | 1.53E-02 | 28.99 | 0.17 ± 0.11 |
| Polyunsaturated FA | ||||||
| C18:2 n-6 | Linoleic | 3.84 ± 0.74 | 1.10E-02 | 5.01E-01 | 19.36 | 0.02 ± 0.07 |
| C18:2 c-9 t-11 | cis-9 and trans-11 octadecadienoic acid methyl esters | 0.3 ± 0.09 | 2.00E-03 | 1.14E-01 | 30.23 | 0.02 ± 0.19 |
| C18:2 c-12 t-10 | cis-12 and trans-10 octadecadienoic acid methyl esters | 0.03 ± 0.01 | 3.14E-05 | 1.30E-04 | 54.44 | 0.19 ± 0.14 |
| C18:3 n-6 | Methyl γ-linoleate | 0.08 ± 0.02 | 8.96E-05 | 3.00E-03 | 24.62 | 0.03 ± 0.33 |
| C18:3 n-3 | Linolenic | 0.24 ± 0.06 | 3.00E-04 | 2.90E-03 | 24.67 | 0.09 ± 0.11 |
| C20:2 n-6 | cis-11,14-eicosadienoic acid methyl ester | 0.06 ± 0.02 | 2.85E-05 | 2.53E-04 | 30.08 | 0.1 ± 0.09 |
| C20:3 n-3 | cis-11,14,17-eicosatrienoic acid methyl ester | 0.26 ± 0.14 | 1.90E-03 | 8.10E-03 | 53.31 | 0.19 ± 0.14 |
| C20:4 n-6 | cis-5,8,11,14-eicosatetraenoic acid methyl ester | 0.01 ± 0 | 3.70E-06 | 1.24E-05 | 49.12 | 0.23 ± 0.15 |
| C20:5 n-3 | cis-5,8,11,14,17-eicosapentaenoic acid methyl ester | 0.07 ± 0.03 | 4.09E-05 | 7.32E-04 | 41.3 | 0.05 ± 0.08 |
| C22:5 n-3 | cis-7,10,13,16,19-docosapentaenoic methyl ester | 0.06 ± 0.03 | 2.28E-04 | 1.50E-02 | 51.35 | 0.02 ± 0.38 |
| C22:6 n-3 | cis-4,7,10,13,16,19-docosahexaenoic acid methyl ester | 0.02 ± 0.02 | 1.00E-04 | 2.00E-04 | 69.71 | 0.3 ± 0.17 |
| Fatty acid groups | ||||||
| SFA | Total saturated fatty acid | 42.53 ± 3.61 | 6.91E+ 00 | 6.68E+ 00 | 8.48 | 0.51 ± 0.16 |
| MUFA | Total monounsaturated fatty acid | 52.51 ± 4.05 | 6.73E+ 00 | 9.91E+ 00 | 7.72 | 0.4 ± 0.17 |
| PUFA | Total polyunsaturated fatty acid | 4.96 ± 0.92 | 1.04E-01 | 6.68E-01 | 18.51 | 0.13 ± 0.15 |
| PUFA/SFA | Ratio between PUFA and SFA | 0.12 ± 0.02 | 7.45E-05 | 2.72E-04 | 16.84 | 0.21 ± 0.14 |
| n-3 | Total omega-3 fatty acids | 0.65 ± 0.18 | 1.40E-03 | 1.92E-02 | 27.49 | 0.07 ± 0.1 |
| n-6 | Total omega-6 fatty acids | 3.99 ± 0.76 | 7.70E-02 | 4.79E-01 | 19.12 | 0.14 ± 0.13 |
| n-6/n-3 | Ratio between n-6 and n-3 | 6.37 ± 1.17 | 3.19E-01 | 6.75E-01 | 18.39 | 0.32 ± 0.16 |
| HI | Health index | 1.49 ± 0.24 | 2.50E-02 | 3.31E-02 | 15.73 | 0.43 ± 0.17 |
aThe concentrations of fatty acids were expressed as a percentage of total fatty acid methyl esters quantified